Insmed (INSM) Current Leases (2010 - 2026)
Insmed (INSM) recorded quarterly Current Leases of $5.0 million in Q1 2026, down 47.12% quarter-over-quarter from $9.5 million in Q4 2025, and up 42.85% on a YoY basis from $3.5 million in Q1 2025.
Insmed (INSM) Current Leases (2010 - 2026) Analysis & Trends
Insmed's Current Leases history runs 13 years deep, the most recent figure standing at $5.0 million for Q1 2026.
- In Q1 2026, Current Leases rose 42.85% year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $5.0 million (up 42.85% YoY), while the FY2025 annual figure was $9.5 million, up 219.79% from the prior year.
- Current Leases was $5.0 million for Q1 2026 at Insmed, down from $9.5 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $9.5 million in Q4 2025 to a low of $125000.0 in Q1 2022.
- Historically, Current Leases has averaged $3.9 million across 5 years, with a median of $3.2 million in 2025.
- The sharpest annual moves came in 2022 and 2023: Current Leases sank 98.05% in 2022, then soared 1861.79% in 2023.
- A 5-year view of Current Leases shows it stood at $6.9 million in 2022, then slumped by 62.22% to $2.6 million in 2023, then gained by 13.45% to $3.0 million in 2024, then soared by 219.79% to $9.5 million in 2025, then plunged by 47.12% to $5.0 million in 2026.
- The last three Current Leases figures came in at $5.0 million (Q1 2026), $9.5 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn | 5.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.01 Mn |
| Dec 31, 2025 | 9.47 Mn |
| Sep 30, 2025 | 3.25 Mn |
| Jun 30, 2025 | 3.15 Mn |
| Mar 31, 2025 | 3.51 Mn |
| Dec 31, 2024 | 2.96 Mn |
| Sep 30, 2024 | 2.87 Mn |
| Jun 30, 2024 | 6.08 Mn |
| Mar 31, 2024 | 2.70 Mn |
| Dec 31, 2023 | 2.61 Mn |
| Sep 30, 2023 | 6.42 Mn |
| Jun 30, 2023 | 4.16 Mn |
| Mar 31, 2023 | 2.16 Mn |
| Dec 31, 2022 | 6.91 Mn |
| Sep 30, 2022 | 5.46 Mn |
| Jun 30, 2022 | 212,000.00 |
| Mar 31, 2022 | 125,000.00 |
| Dec 31, 2021 | 9.53 Mn |
| Sep 30, 2021 | 5.95 Mn |
| Jun 30, 2021 | 1.16 Mn |